Wayne E Anderson DO A Medical Corporation
Board Certified Neurology
Board Certified Pain Management
OFFICE NEWS: Our office is undergoing a transformation from an older electronic medical record system to a new electronic system. The process is, shall we say, complex!
We are almost there! Once the transition to the new system is complete, we will ask patients to verify their medical information. By asking patients to review their information, not only are patients better empowered to be a part of the medical team, any errors involved in transferring data to the new system can be found and corrected.
We also have additional information available in the frequently asked questions section (including refill policies and the like) and in the calendar & contact us sections.
MEDICAL NEWS: As part of the medical treatment and reassessment cycle, it is important to keep up on the news that can impact a patient's diagnosis, treatment, medications and overall quality of life.
NEWS FROM JULY 2008
- Coffee and Multiple Sclerosis
- As the research keeps showing benefits of coffee consumption, there was a study in mice suggested that coffee consumption of 6-8 cups per day could help halt the progression of multiple sclerosis. This follows on the heels of studies showing that 6-8 cups of coffee did not shorten life, possibly helped diabetes, parkinsonism, etc. and prevented various cancers. Of course, these have not been proven in humans. However, it makes us feel a little better as we feed our Starbuck's addiction!
- Fentora was NOT approved for non-cancer pain
- Many chronic pain patients were wondering if Fentora, a fast-acting opioid medication for the rapid relief of breakthrough pain currently FDA-approved for cancer pain, would be FDA-approved for back pain and/or neuropathic pain in the fall of 2008. FDA-approval for non-cancer pain would allow the company to provide medical and safety information to those physicians who prescribe it for non-cancer pain. An advisory committee of the FDA, however, has decided that it should not be FDA-approved for non-terminal/non-cancer pain, citing concerns about the possibility that the medication might be abused.
- Cymbalta is now
FDA approved for FIBROMYALGIA
- Cymbalta joins Lyrica as a medication FDA-approved for fibromyalgia pain. Currently, these are the only two medications that have FDA-approval. That means that although many medications and other treatments are used frequently, the makers of Cymbalta (and Lyrica) were able to show that the benefits of their medication in fibromyalgia were significant enough to warrant the government's "stamp of approval" for that particular use.
- Cymbalta - maybe for chronic pain
- The company that makes Cymbalta, an antidepressant that also was found efficacious for diabetic neuropathy pain, may be efficacious for chronic pain. The company has submitted a supplemental drug application to the FDA (which means they are providing research data and information) to see if the FDA agrees that the medication may be advertised for the treatment of chronic pain of ANY type.
- Magnetic stimulation for migraine headache
- Recent studies have suggested that magnetic stimulation of the brain can reduce or abort migraine headache. Previously, it was suspected that magnetic stimulation could help but the magnets were huge, immobile things. Now, a new company is testing a hand-held device that can be set on top of the head. With a button press, a headache can be treated. We will see how the studies go. Yes, it seems safe.
NEWS ACHIVE: please click here for the news archives. Please note that since medical information changes rapidly, some of the information presented may have been disproven or changed in the days, months and years since.
NEWS
We are pleased that you are visiting our website. We hope you find it helpful and informative.